期刊文献+

优质护理配合唑来膦酸注射液治疗老年骨质疏松症的临床效果分析 被引量:1

The Clinical Effect of High Quality Nursing Combined with Zoledronic Acid Injection in the Treatment of Senile Osteoporosis
下载PDF
导出
摘要 目的:探索优质护理配合唑来膦酸注射液治疗老年骨质疏松症的临床效果。方法:选择笔者所在医院与2017年1月-2018年4月收治的老年骨质疏松症患者160例,将患者随机分为两组,对照组行常规护理配合唑来膦酸注射液滴注,研究组行优质护理合唑来膦酸注射液滴注,对比两组的骨密度情况及对护理服务的满意率。结果:研究组治疗后的腰椎、髋骨的骨密度为(0.895±0.064)、(0.869±0.127)g/cm^3,高于对照组的(0.785±0.073)、(0.782±0.104)g/cm^3(P<0.05);研究组不良反应发生率6.2%,低于对照组的17.5%(P<0.05);研究组对护理服务满意率为93.8%,高于对照组的81.3%(P<0.05)。结论:采用优质护理配合唑来膦酸注射液治疗老年骨质疏松症能够提高骨密度,降低不良反应的发生率,增加患者对护理服务的满意度,具有积极的应用效果,适合推广应用。 Objective:To explore the clinical effect of high quality nursing combined with Zoledronic Acid Injection in the treatment of senile osteoporosis.Method:A total of 160 elderly osteoporosis patients in our hospital and admitted from January 2017 to April 2018 were randomly divided into two groups.The control group received routine nursing combined with Zoledronic Acid Injection,and the study group received high-quality nursing combined with Zoledronic Acid Injection.The bone mineral density and satisfaction rate of nursing service were compared between the two groups.Result:Bone mineral density of lumbar spine and hip in the study group were(0.895±0.064),(0.869±0.127)g/cm^3,higher than(0.785±0.073),(0.782±0.104)g/cm^3 in the control group(P<0.05).The incidence of adverse reactions was 6.2%,less than 17.5%in the control group(P<0.05).The satisfaction rate of nursing service was 93.8%,higher than 81.3%in the control group(P<0.05).Conclusion:high quality nursing combined with Zoledronic Acid Injection can improve the bone mineral density,reduce the incidence of adverse reactions,and increase the satisfaction of patients with nursing services.
作者 郑淑芬 ZHENG Shufen(Zhangzhou Hospital of Traditional Chinese Medicine,Zhangzhou 363000,China)
机构地区 漳州市中医院
出处 《中外医学研究》 2020年第1期91-93,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 唑来膦酸注射液 优质护理 骨质疏松症 不良反应 Zoledronic Acid Injection Quality nursing Osteoporosis Adverse reactions
  • 相关文献

参考文献13

二级参考文献74

  • 1邑晓东,卢海霖,宫树一.医用骨水泥对腰椎椎弓根钉固定的影响[J].中华外科杂志,2004,42(23):1427-1429. 被引量:24
  • 2陈佩珊,李超群.健康教育在骨质疏松症患者中的应用[J].国际护理学杂志,2007,26(1):98-100. 被引量:6
  • 3刘斌,戎利民,谢沛根,等.PVP联合唑来膦酸治疗绝经后骨质疏松性椎体骨折的疗效分析[C].中华医学会骨科学分会微创学组2011年年会论文集,2011:264-271.
  • 4Deeks ED,Perry CM.Zoledronic acid:a review of its use in the treatment of osteoporosis[J].Drugs Amp Aging,2008,25(11):963-986.
  • 5Procianoy F,Procianoy E.Orbital inflammatory disease secondary to a single dose administration of zoledronic acid for treatment of postmenopausal osteoporosis[J].Osteoporosis international,2010,21(6):1057-1058.
  • 6Russell RG,Watts NB, Ebetino FH. Mechanisms of action of bi- sphosphonates: Similarities and differences and their potential in- fluenceon clinical efficacy [J]. Osteoporos Int, 2008,19 (6) :733 - 759.
  • 7Lylev KW, Emetic CS, Magaziner JS, et al. Zoledronic acid and clinie: fractures and mertality after hip fracture[J]. N Engl J Med,2007,357(181) :1799 - 1809.
  • 8Sharkey NA, Vyiuiam CI,Guerin JB. The role of exercise in the prevention and treatment of osteoporosis and osreoarthritis[J]. Nurs Clin North(Am),2000,35(1) :7 - 9.
  • 9Ailinger RL,Lesus H,Braun MA. Revision of the facts on osteo- porosis quiz[J]. Nuts Res,2003,52(3):200.
  • 10Gramer JA, Amonkar MM, Hebbom A,et al. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis[J]. Current Medical Research and Opinion, 2005,21 (12) : 1453 - 1460.

共引文献32

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部